Company
LON:VAL
ValiRx is a drug development company, which focuses on the translation of scientific innovation into clinical candidates for cancer, related conditions and women’s health. The company's specialised business model connects science, finance and commerce to accelerate early-stage drug development. It identifies proprietary and novel drug candidates with the potential to improve patient lives, providing the expertise and investment required for optimised development and value creation.
310 stories · page 3 of 16
ValiRX said it expects to announce the outcome of talks with European High Growth “shortly” and no longer intends to enter into further arrangements with the investor.
Investments and investor services
The UK's index of leading shares finished the first day of the trading week around 46 points higher at 7,378
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
A look at some of the biggest risers and fallers in London on Wednesday
Investments and investor services
The UK blue-chip share index finished up around four points at 7,218
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
Here's Wednesday's look at the major stock market movers
VAL201 has been shown to be safe and well tolerated during phase I/II trials and, crucially, there was “primary evidence” of the drug’s activity in patients
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
A look at the day's major movers, including Pressure Technologies. Clontarf Technologies, Oxford Biomedica, Trafalgar Property, Yü, Proton Power and Frontier IP
The firm said its working capital position is dependent on new funds being made available to it and anticipates that the investor will provide it with additional funds under the new facility
Archive
The UK blue-chip index ended 7.78 points lower at 7,265.98, just off the day's worst level of 7,263.80 after a topsy-turvey session which saw it hit a session high of 7,314.85 early on
Archive
A look at some of the top risers and fallers on the London Stock Exchange on Wednesday, including 21st Century Technology, Thruvision, Hargreaves Services, Management Resource Solutions, SafeCharge International, IG Group, Pets at Home, and
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
The company has provided some detail on a potential second financing round
Archive
The Footsie closed out at 7,334 - up around five points, while mid-cap index was firmly lower- down 129 points at 19,307
Archive
A look at some of the biggest risers and fallers in London on Thursday
Archive
A glance at some of the day's highlights from the Proactive Investors newswire
It has bought the assets of a Finnish biotech and set out the outline for a collaboration with a firm that offers specialist financing
